Active intervention in hospital test request panels pays.

In healthcare settings, test panels are commonly used to streamline the ordering of diagnostic tests. These panels help ensure that essential tests are not overlooked. However, the use of test panels can also result in unnecessary or redundant testing, as not all tests in a panel are relevant for every patient. Prior research has shown that such redundancy increases healthcare costs without necessarily improving diagnostic accuracy or patient outcomes. While the convenience of test panels is well established, the potential for overuse remains a concern. No prior work had resolved how to balance efficiency and cost-effectiveness in panel design. That uncertainty drove the need for a structured approach to panel optimization. The role of laboratory staff in shaping test panels has been underexplored in this context. This gap motivated an investigation into how active involvement of laboratory professionals could improve panel design and reduce unnecessary testing.

This study aimed to evaluate the impact of laboratory staff involvement in the organization of test panels on test use and associated costs. The specific problem addressed was the overuse of diagnostic tests resulting from redundant or unnecessary panel components. The motivation stemmed from the need to reduce healthcare expenditure without compromising diagnostic quality. The researchers proposed that restructuring test panels could lead to more efficient test ordering. They hypothesized that removing redundant tests would decrease overall test volume. This approach could also lead to cost savings for the healthcare institution. The study sought to quantify these effects through a structured panel reorganization initiative. The goal was to assess whether active laboratory staff intervention could yield measurable savings and improved efficiency.

The study involved a systematic review and reorganization of existing test panels at a hospital. Laboratory staff led the initiative by evaluating all current panels for redundancy and relevance. They proposed new panels based on clinical needs and test frequency. The number of panels was reduced from 171 to 60 through this process. The new panels were designed to include only essential tests for each clinical scenario. The researchers also established a policy requiring laboratory staff to review all future panel proposals. This ensured ongoing oversight of panel composition. The impact of the reorganization was measured by comparing test volumes before and after the intervention.

The reorganization reduced the number of tests in panels by 17.7%, or 60 tests. This change theoretically should have led to a 4.5% reduction in test orders. However, 14% of the removed tests were ordered individually instead of being included in panels. As a result, the actual reduction in test orders was 3.9%. This led to an annual cost saving of approximately €58,000. The saving represented 4.5% of the total cost of tests ordered via panels. When the unchanged metabolic panel was excluded, savings increased to 7–8%. These findings suggest that panel optimization can yield meaningful cost reductions.

The authors suggest that active involvement of laboratory staff in panel organization can reduce test use and lower costs. They propose that removing redundant tests from panels leads to measurable savings. The study indicates that 17.7% fewer tests were included in panels after reorganization. The researchers suggest that 3.9% fewer tests were ordered overall. They propose that the savings amounted to €58,000 annually. The authors suggest that excluding the unchanged metabolic panel increased savings to 7–8%. They propose that ongoing oversight of panel proposals is essential to maintain efficiency. The findings suggest that laboratory staff can play a key role in optimizing diagnostic test use.